Skip to main content

coronavirus Archives

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

May. 12, 2021—Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

Read more


Fauci shares lessons learned during pandemic response with Vanderbilt MPH students

May. 12, 2021—Anthony Fauci, MD, chief medical adviser to President Joe Biden’s administration and director of the National Institute of Allergy and Infectious Diseases (NIAID), recently met virtually with students of Vanderbilt University School of Medicine’s Master of Public Health (MPH) program to answer questions about lessons learned during the pandemic and to share career advice.

Read more


VUMC to lead national study to treat severe COVID complications

May. 6, 2021—The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

Read more


Flexibility, trust: Takeaways from Leadership Assembly

May. 6, 2021—The flexibility and adaptability of Vanderbilt University Medical Center has been center stage as the pressures of COVID-19 and ongoing strategic imperatives have transformed how and where care is delivered.

Read more


VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Apr. 29, 2021—Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

Read more


Vaccinated patients avoiding hospital stays as pandemic rages on

Apr. 23, 2021—Vanderbilt University Medical Center (VUMC) is reporting only four persons who have been fully vaccinated against COVID-19 have been diagnosed with COVID during an acute care hospitalization at its facilities over the past four months.

Read more


VUMC aids national effort to repurpose drugs for COVID-19

Apr. 19, 2021—Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

Read more


Extracting accurate COVID data from scanned forms

Apr. 19, 2021—A switch to paper forms during the COVID-19 pandemic might have hobbled research, but using software with a novel user interface made it possible to accurately extract information from scanned forms.

Read more


VUMC creates new Adult Post-acute COVID Clinic

Apr. 8, 2021—On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.

Read more


COVID-19 lessons: VUMC, other hospital leaders pinpoint opportunities in National Academy Review

Apr. 7, 2021—The versatility of health systems in the national COVID-19 response underscore the challenges and opportunities for leaders to strengthen and design systems to better care for communities and respond to ever-changing needs, top health care delivery system leaders outline in a discussion paper for the National Academy of Medicine (NAM).

Read more


U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC

Apr. 6, 2021—The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.

Read more


COVID recovery included long stay on ECMO, double-lung transplant

Apr. 1, 2021—Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more